VIVS VivoSim Labs, Inc. Common Stock BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Best Biotech Stocks 2026 →

VivoSim Labs (VIVS) Stock: Buy, Sell, or Hold?

$0.29
+0.17 (+142.92%) ▲
5d: +111.39% 30d: +64.69% 90d: +1.92%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (6%)
Quality Score
36/100
Position
EXTENDED
30-Day Fair Range
$0.12 – $0.19
Position: EXTENDED
Options IV & Volume
MODERATE Vol
MODERATE volume confirmation
Support / Resistance
$0.12 / $0.18
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: VIVS is 53.4% above its trading range ($0.19). While momentum could continue, risk/reward favors waiting for a pullback.

Get Alerted When VIVS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: VIVS is currently trading at $0.29, which is considered extended relative to its 30-day fair value range of $0.12 to $0.19.

Technical Outlook: Technically, VIVS is in a strong downtrend. The price is approaching resistance at $0.18. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 142.9% recently.

Market Sentiment: VIVS scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $0.12 - $0.19
Company Quality Score 36/100 (SELL)
Volume Confirmation MODERATE
Confidence Score 5.9%

Trading Range & Key Levels

30-Day Trading Range $0.12 - $0.19
Current vs Trading Range EXTENDED
Support Level $0.12
Resistance Level $0.18
Current Trend Strong Downtrend
Technical data as of Nov 18, 2026

Institutional Signals, 13F Whale Activity & Setup Structure

Quantitative Research Feed
Phase & Gamma Walls BREAKDOWN
Days in Phase: 73d (50% conf)

Quantitative Signal Breakdown

  • BEARISH: Price significantly overextended (+53.4% above its trading range)
  • BEARISH: Weak technical setup (5/100)
  • BULLISH: Strong upward momentum (+142.9%)
  • WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Revenue Growth (YoY) -51.4%
Share VIVS Analysis

Share this live VIVS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (VIVS)

Neutral 18 Retail Mentions
Retail Stream Volume
18 msgs
24h retail stream
Last Tracked
Nov 20, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits is flooded with bullish sentiment towards $VIVS, with traders predicting price targets of $1 and beyond. The latest Yahoo Finance news reports VivoSim Labs securing a seven-figure pharmaceutical testing agreement, leading to increased revenue growth expectations for Fiscal 2027.
Key Retail Themes: Bullish sentiment around $VIVS Company's growth prospects
Aggregated from r/wallstreetbets, r/stocks & retail trader streams. View All Trending Reddit & WSB Stocks →
Last updated: November 20, 2026 5:04 AM ET
Data refreshes hourly during market hours. Next update: 6:04 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for VIVS.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
DNLI
Denali Therapeutics Inc
STRONG BUY
20 analysts
$36 50 HOLD
WVE
Wave Life Sciences Ltd
STRONG BUY
21 analysts
$17 49 HOLD
ARWR
Arrowhead Pharmaceutical…
STRONG BUY
15 analysts
$106 57 HOLD
SRRK
Scholar Rock Holding Corp
STRONG BUY
18 analysts
$70 40 SELL
EPRX
Eupraxia Pharmaceuticals…
STRONG BUY
13 analysts
$17 53 HOLD
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals